Multiple Endpoints in Clinical Trials: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 21, 2022
April 17, 2024
d08a7428-0534-4dad-83d9-37a60fc5fe62
Related Documents
E8(R1) General Considerations for Clinical Studies
Guidance DocumentApril 8, 2022Center for Drug Evaluation and Research
Homeopathic Drug Products Guidance for FDA Staff and Industry
Guidance DocumentDecember 7, 2022Center for Drug Evaluation and Research
Population Pharmacokinetics: Guidance for Industry
Guidance DocumentFebruary 3, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox